603235 Stock Overview
Jiangxi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
JiangXi Tianxin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.55 |
| 52 Week High | CN¥32.46 |
| 52 Week Low | CN¥19.13 |
| Beta | 0 |
| 1 Month Change | 0.085% |
| 3 Month Change | 6.22% |
| 1 Year Change | -24.86% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603235 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 4.2% | 0.4% | -0.4% |
| 1Y | -24.9% | -27.5% | -17.6% |
Return vs Industry: 603235 exceeded the CN Personal Products industry which returned -29.2% over the past year.
Return vs Market: 603235 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 603235 volatility | |
|---|---|
| 603235 Average Weekly Movement | 5.1% |
| Personal Products Industry Average Movement | 6.4% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603235 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603235's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 2,471 | Zhongli Pan | www.txpharm.com |
Jiangxi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. It offers products of vitamin B6, vitamin B9, folic acid, biotin, ascorbyl palmitate, and vitamin D3 for use as bulk pharmaceutical chemicals, food additives, and feed additives, as well as in other fields. The company was founded in 2004 and is based in Leping, China.
JiangXi Tianxin Pharmaceutical Co., Ltd. Fundamentals Summary
| 603235 fundamental statistics | |
|---|---|
| Market cap | CN¥10.31b |
| Earnings (TTM) | CN¥483.84m |
| Revenue (TTM) | CN¥2.04b |
21.3x
P/E Ratio5.0x
P/S RatioIs 603235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603235 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.34b |
| Gross Profit | CN¥705.47m |
| Other Expenses | CN¥221.63m |
| Earnings | CN¥483.84m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 24, 2024
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 34.55% |
| Net Profit Margin | 23.70% |
| Debt/Equity Ratio | 2.4% |
How did 603235 perform over the long term?
See historical performance and comparison